SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Golding, J.
Right arrow Articles by Baldwin, l. J. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Golding, J.
Right arrow Articles by Baldwin, l. J. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Maternal Anti-nauseants and Clefts of Lip and Palate

J. Golding

Unit of Clinical Epidemiology, University of Oxford, Old Road, Headington, Oxford OX3 7LF, U.K.

S. Vivian

Unit of Clinical Epidemiology, University of Oxford, Old Road, Headington, Oxford OX3 7LF, U.K.

late J. A. Baldwin

Unit of Clinical Epidemiology, University of Oxford, Old Road, Headington, Oxford OX3 7LF, U.K.

1 Data on drug prescriptions were obtained from the general practitioners of 196 women who had had infants with clefts of lip or palate and those of 407 control women, matched for age, parity, social class and year of delivery.

2 There was no excess of index women who had presented with nausea or vomiting.

3 There was a significant excess (12 cases, nine controls, P<0.02) of women who had been prescribed Debendox (the 3-constituent, or pre-1976, formulation of Bendectin) in early pregnancy.

4 This result was not thought to be conclusive evidence of a teratogenic effect but caution in prescribing is advised pending more extensive studies.

Human & Experimental Toxicology, Vol. 2, No. 1, 63-73 (1983)
DOI: 10.1177/096032718300200105


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement